Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 11 PAGES: 35

Shandong Weigao Group Medical Polymer Company Limited (1066) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Shandong Weigao Group Medical Polymer Company Limited (Weigao)

More Info
									           Shandong Weigao Group Medical Polymer Company Limited (1066) -
                    Financial and Strategic SWOT Analysis Review
        Reference Code: GDME12707FSA                                                                                                                         Publication Date: DEC 2013



       Table of Contents
       Table of Contents ............................................................................................................................................................................... 1
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Section 1 - About the Company.......................................................................................................................................................... 5
       Shandong Weigao Group Medical Polymer Company Limited - Key Facts ........................................................................................ 5
       Shandong Weigao Group Medical Polymer Company Limited - Key Employees ............................................................................... 6
       Shandong Weigao Group Medical Polymer Company Limited - Key Operational Employees ........................................................... 7
       Shandong Weigao Group Medical Polymer Company Limited - Major Products and Services .......................................................... 8
       Shandong Weigao Group Medical Polymer Company Limited - History ............................................................................................ 9
       Shandong Weigao Group Medical Polymer Company Limited - Company Statement ..................................................................... 11
       Shandong Weigao Group Medical Polymer Company Limited - Locations And Subsidiaries........................................................... 12
          Head Office ................................................................................................................................................................................... 12
          Other Locations & Subsidiaries ..................................................................................................................................................... 12
          Joint Venture................................................................................................................................................................................. 12
       Section 2 – Company Analysis ......................................................................................................................................................... 13
       Shandong Weigao Group Medical Polymer Company Limited - Business Description .................................................................... 13
       Shandong Weigao Group Medical Polymer Company Limited - SWOT Analysis............................................................................. 15
          SWOT Analysis - Overview........................................................................................................................................................... 15
          Shandong Weigao Group Medical Polymer Company Limited - Strengths ................................................................................... 15
             Strength - Strong Product Portfolio ........................................................................................................................................... 15
             Strength - Robust Sales and Marketing Presence .................................................................................................................... 15
             Strength - Consistent Top-Line Growth ..................................................................................................................................... 15
          Shandong Weigao Group Medical Polymer Company Limited - Weaknesses.............................................................................. 16
             Weakness - Geographical Concentration in China .................................................................................................................... 16
          Shandong Weigao Group Medical Polymer Company Limited - Opportunities ............................................................................. 16
             Opportunity - Demographic Trends ........................................................................................................................................... 16
             Opportunity - Market Growth in Emerging Countries ................................................................................................................. 16
             Opportunity - Strategic Business Initiatives ............................................................................................................................... 16
          Shandong Weigao Group Medical Polymer Company Limited - Threats ...................................................................................... 17
             Threat - Industry consolidation .................................................................................................................................................. 17
             Threat - Competitive Landscape ............................................................................................................................................... 17
             Threat - Stringent Government Regulations .............................................................................................................................. 17
       Shandong Weigao Group Medical Polymer Company Limited - Key Competitors ........................................................................... 18
       Section 3 – Company Financial Ratios ............................................................................................................................................. 19
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 19
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 19
       Performance Chart ........................................................................................................................................................................... 21
       Financial Performance...................................................................................................................................................................... 21
       Financial Ratios - Interim Ratios....................................................................................................................................................... 22



Shandong Weigao Group Medical Polymer Company Limited                                                                                                         Reference Code: GDME12707FSA
(1066) - Financial and Strategic SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 23
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 24
          Shandong Weigao Group Medical Polymer Company Limited, Medical Equipment, Deals By Year, 2007 to YTD 2013 ............. 24
          Shandong Weigao Group Medical Polymer Company Limited, Medical Equipment, Deals By Type, 2007 to YTD 2013 ............. 25
          Shandong Weigao Group Medical Polymer Company Limited, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
          ...................................................................................................................................................................................................... 26
          Shandong Weigao Group Medical Polymer Company Limited, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
          ...................................................................................................................................................................................................... 27
       Shandong Weigao Group Medical Polymer Company Limited, Recent Deals Summary ................................................................. 28
       Section 5 – Company’s Recent Developments ................................................................................................................................ 29
          Shandong Weigao Group Medical Polymer Company Limited, Recent Developments ................................................................ 29
             Nov 16, 2012: Weigao Reports Revenue Of RMB980.8m In Q3 2012...................................................................................... 29
             Aug 15, 2012: Weigao Reports Revenue Of RMB1 Billion In Q2 2012 ..................................................................................... 29
             May 30, 2012: Weigao Reports Revenue Of RMB862m In Q1 2012 ........................................................................................ 30
             Mar 29, 2012: Weigao Reports Revenue Of RMB3.2 Billion In 2011 ........................................................................................ 30
       Section 6 – Appendix ....................................................................................................................................................................... 31
          Methodology ................................................................................................................................................................................. 31
          Ratio Definitions ............................................................................................................................................................................ 31
          About GlobalData ......................................................................................................................................................................... 35
          Contact Us .................................................................................................................................................................................... 35
          Disclaimer ..................................................................................................................................................................................... 35




Shandong Weigao Group Medical Polymer Company Limited                                                                                                              Reference Code: GDME12707FSA
(1066) - Financial and Strategic SWOT Analysis Review
Source : www
								
To top